Gary Clark: Unfiltered

The sustainable materials firm saw net income jump 60% after a planned shutdown created a record backlog, setting the stage for a strong Q3.

A historic U.S. executive order reclassifies cannabis, opening the door for pharmaceutical products. One Canadian firm is already years ahead of the curve.

With a massive capital raise and rapid microreactor progress, NANO Nuclear is positioning itself to power the AI boom and lead a new nuclear renaissance.

WhiteFiber lands a 10-year, 40 MW anchor deal with AI provider Nscale, validating its high-density strategy and fueling North Carolina's tech boom.

President Trump’s historic order to reschedule cannabis unlocks a new era, promising massive tax relief, medical research, and a path toward normalization.

For the first time, Medicare and Medicaid will cover CBD products for senior cancer patients, a landmark decision with massive implications for patients and markets.

Vizsla Silver acquires key claims from major Fresnillo, fueling its flagship Panuco project's growth and solidifying its position in a historic silver belt.

New data reveals a novel wound gel is successfully treating conditions previously deemed unhealable, offering hope against chronic wounds and antibiotic resistance.

Armed with breakthrough data on an AI-designed therapy that penetrates the brain, Rakovina Therapeutics heads to JPM Week to court major partners.

The Nasdaq-listed restaurant operator confirms its board and auditor, signaling stability as it navigates a volatile stock performance and dynamic F&B sector.

With a $60M backing from a mystery investor, U Power plans to bring its AI-driven battery swapping tech to Southern Europe. Can it succeed?

Anixa Biosciences now fully controls its breast cancer vaccine after promising Phase 1 data. What does this strategic move mean for investors and medicine?

Palantir's DGSI contract renewal isn't just a deal; it's a story of strategic reliance, political tension, and the bedrock of its business model.

Beyond a simple date change for its $10M dividend, Dominari Holdings is signaling a major strategic shift, funded by investment gains and aimed at AI.

A Chinese eco-tech firm is betting on India's infrastructure boom. Can its waste-to-value solutions capture a piece of this massive, competitive market?

Decibel Cannabis secured approval for a potential 50-1 share consolidation. Is this a sign of weakness or a savvy move to fuel its global expansion?

SAGA Metals' drill success and C$6M funding fuel a major critical mineral play in Labrador, aiming to secure North America's industrial future.

From electric cars to crypto custody, Jiuzi Holdings is chasing a $1B funding deal. A look at the massive risks and institutional hunger behind the pivot.

With full control of a prized Turkish zinc mine, Pasinex bets big on a 1,000-meter deep dig. Can this capital-intensive play pay off in a shifting market?

As logistics giant Ryder plans a seamless CEO shift from Sanchez to insider John Diez, we analyze the strategy of continuity in a volatile market.